Gyroscope Therapeutics Limited
5 clinical trials · Sponsor
◉ Watch Gyroscope Therapeutics Limited
| Record | Firm | Date |
|---|---|---|
| HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005 (NCT04566445) | Gyroscope Therapeutics Limited | 2020-09-28 |
| EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005 (NCT04437368) | Gyroscope Therapeutics Limited | 2019-04-26 |
| GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD) (NCT03894020) | Gyroscope Therapeutics Limited | 2019-01-08 |
| FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD (NCT03846193) | Gyroscope Therapeutics Limited | 2018-12-17 |
Track Gyroscope Therapeutics Limited automatically
Every clearance here is in the API, with alerts when new ones post.